Day One Biopharmaceuticals Inc (DAWN)
13.27
-0.33
(-2.43%)
USD |
NASDAQ |
May 31, 16:00
13.27
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Market Cap: 1.160B for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.160B |
| May 30, 2024 | 1.189B |
| May 29, 2024 | 1.202B |
| May 28, 2024 | 1.189B |
| May 24, 2024 | 1.203B |
| May 23, 2024 | 1.212B |
| May 22, 2024 | 1.278B |
| May 21, 2024 | 1.292B |
| May 20, 2024 | 1.396B |
| May 17, 2024 | 1.413B |
| May 16, 2024 | 1.401B |
| May 15, 2024 | 1.435B |
| May 14, 2024 | 1.452B |
| May 13, 2024 | 1.403B |
| May 10, 2024 | 1.398B |
| May 09, 2024 | 1.431B |
| May 08, 2024 | 1.434B |
| May 07, 2024 | 1.493B |
| May 06, 2024 | 1.451B |
| May 03, 2024 | 1.500B |
| May 02, 2024 | 1.535B |
| May 01, 2024 | 1.546B |
| April 30, 2024 | 1.494B |
| April 29, 2024 | 1.440B |
| April 26, 2024 | 1.304B |
| Date | Value |
|---|---|
| April 25, 2024 | 1.154B |
| April 24, 2024 | 1.327B |
| April 23, 2024 | 1.454B |
| April 22, 2024 | 1.344B |
| April 19, 2024 | 1.307B |
| April 18, 2024 | 1.376B |
| April 17, 2024 | 1.298B |
| April 16, 2024 | 1.277B |
| April 15, 2024 | 1.210B |
| April 12, 2024 | 1.203B |
| April 11, 2024 | 1.229B |
| April 10, 2024 | 1.259B |
| April 09, 2024 | 1.256B |
| April 08, 2024 | 1.220B |
| April 05, 2024 | 1.273B |
| April 04, 2024 | 1.241B |
| April 03, 2024 | 1.363B |
| April 02, 2024 | 1.384B |
| April 01, 2024 | 1.412B |
| March 28, 2024 | 1.443B |
| March 27, 2024 | 1.380B |
| March 26, 2024 | 1.356B |
| March 25, 2024 | 1.312B |
| March 22, 2024 | 1.359B |
| March 21, 2024 | 1.316B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
354.14M
Minimum
May 27 2022
1.952B
Maximum
Aug 12 2022
1.216B
Average
1.256B
Median
Market Cap Benchmarks
| Revolution Medicines Inc | 6.324B |
| Iovance Biotherapeutics Inc | 2.485B |
| Beam Therapeutics Inc | 1.961B |
| Zentalis Pharmaceuticals Inc | 843.64M |
| Perspective Therapeutics Inc | 859.23M |
Market Cap Related Metrics
| PS Ratio | 0.587 |
| PEG Ratio | 0.0736 |
| Price to Book Value | 3.907 |
| Price | 13.27 |
| Earnings Yield | -18.91% |
| PEGY Ratio | 0.0736 |
| Operating PE Ratio | 4.318 |
| Normalized PE Ratio | 6.264 |